Trial intelligence / Profile preview

Prophylactic Cotrimoxazole in Transperineal Prostate Biopsy

NCT04985110Phase 2Unknown

Sponsor
Universitas Indonesia
Start
Jul 2021
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Bacteriuria, urinary tract infection (UTI) and sepsis comparing Cotrimoxazole with Placebo (2 arms). Primary endpoint: Incidence of perioperative infection complications at 14 days. Status: unknown.

02

Drugs

trimethoprim + sulfamethoxazole
03

Conditions

Bacteriuriaurinary tract infection (UTI)sepsis

Beyond the preview

Go deeper on NCT04985110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04985110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call